Ivonescimab for leiomyosarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Apr 2026: Trial started, NCT07516925
  2. 8 Apr 2026: Trial registered, NCT07516925

The trials

NCT07516925: A Study of Ivonescimab in People With Leiomyosarcoma

State
Under way
Phase
Phase 2
People
20 planned
Started
1 Apr 2026
Primary completion
Apr 2029
Arms
Ivonescimab
Results
None posted
  1. 1 Apr 2026: Trial started
  2. 8 Apr 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Ivonescimab 10 mg/kg, Ivonescimab 20 mg/kg, Ivonescimab Injection, Ivonescimab/surgery.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.